Overview A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice. Status: Completed Trial end date: 2009-10-01 Target enrollment: Participant gender: Summary This prospective surveillance trial will gather safety information for Optison when it is used in routine practice. Phase: Phase 4 Details Lead Sponsor: GE Healthcare